CIK 0001762303
- Non-accelerated filer
- Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202578762
- Phone
- +1 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-21 | PERRY MICHAEL S Director | Option exercise | +150,000 | $5.99 | $899K | 379,543 |
| 2022-11-21 | PERRY MICHAEL S Director | Sale | −150,000 | $7.18 | $1.1M | 229,543 |
| 2022-11-21 | PERRY MICHAEL S Director | Option exercise · Stock Options (Right to Buy) | −150,000 | 0 | ||
| 2022-09-01 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +2,980 | 300,983 | ||
| 2022-09-01 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +3,450 | 6,900 | ||
| 2022-06-01 | PERRY MICHAEL S Chief Executive Officer | Other disposition | −23,754 | 297,958 | ||
| 2022-02-24 | PERRY MICHAEL S Chief Executive Officer | Sale | −10,812 | $8.74 | $94K | 321,712 |
| 2022-02-23 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +23,753 | 326,564 | ||
| 2022-02-23 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +5,960 | 332,524 | ||
| 2022-02-23 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +3,450 | 3,450 | ||
| 2021-12-22 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +23,800 | 255,171 | ||
| 2021-12-22 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +23,820 | 278,991 | ||
| 2021-12-22 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +23,820 | 302,811 | ||
| 2021-12-22 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +13,800 | 13,800 | ||
| 2021-12-22 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +13,800 | 13,800 | ||
| 2021-12-22 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +13,800 | 13,800 | ||
| 2021-09-01 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +23,754 | 248,858 | ||
| 2021-09-01 | PERRY MICHAEL S Chief Executive Officer | Sale | −11,220 | $20.68 | $232K | 237,638 |
| 2021-06-02 | PERRY MICHAEL S Chief Executive Officer | Sale | −23,000 | $17.33 | $399K | 225,104 |
| 2020-09-16 | PERRY MICHAEL S Chief Executive Officer | Sale | −9,000 | $27.41 | $247K | 425,087 |
Page 1 of 2 · 27 trades